Stocktoria
IDEAYA Biosciences, Inc. IDYA
IDEAYA Biosciences, Inc. statistics & valuation
Market cap$3.5B
P / S16.0×
P / B3.4×
Net margin-52.0%
Return on equity-11.1%
FCF margin-33.6%
Return on capital-15.2%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -72.8% | -4671.1% | -574.9% | -122.7% | -179.9% | -180.9% | — | — |
| Net margin | -52.0% | -3921.1% | -483.0% | -115.2% | -178.1% | -176.6% | — | — |
| FCF margin | -33.6% | -3592.0% | -502.9% | -177.9% | -209.1% | 281.3% | — | — |
| Return on assets | -10.2% | -24.4% | -17.4% | -15.1% | -13.0% | -11.6% | -37.1% | -35.6% |
| Return on equity | -11.1% | -25.9% | -18.2% | -16.8% | -16.5% | -17.4% | -41.8% | 70.2% |
| Current ratio | 11.34 | 14.97 | 19.65 | 11.68 | 5.56 | 7.47 | 14.65 | 16.75 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.